Breaking News, Collaborations & Alliances

PRA Partners with Frontage Labs for Testing Services

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PRA International has entered an agreement with Frontage Laboratories, Inc., enabling PRA Early Development Services’ U.S. Clinical Pharmacology Center to offer full analytical lab testing services to its Phase I – IV trial services in North America.  
   
Under the collaboration agreement, Frontage Laboratories will offer specialized cGMP/GLP compliant bioanalytical services through PRA. Services also include pharmacokinetic and biostatistical consultancy and data support, including data management, biostatistical and PK/PD analysis, and ICH-compliant report writing. Frontage operates a bioanalytical and biomarker research center in Malvern, PA.  
   
PRA’s facility near Kansas City, MO, runs Phase I and Phase IIa studies with a focus on first in human studies and other complex PK studies. Adding bioanalytical testing services aligns the clinical and lab processes in an effort to save time by avoiding clinical trial delays.
   
Dr. Wim Tamminga, senior director, PRA Early Development Services commented, “We selected Frontage Laboratories as part of our strategy to offer clients a seamless package consisting of clinical and laboratory services. This service allows us to accelerate Phase I studies and to give sponsors the ability to make better decisions earlier in the drug development process. Frontage is the right partner for this collaboration because they are already a well-established provider of cGMP/GLP compliant testing services. Quality of service, location, and scientific knowledge are what make Frontage Laboratories the best collaborative partner for our bioanalytical services.”
   
Song Li, chief executive officer, Frontage Laboratories said, “We are delighted that PRA chose Frontage Laboratories to assist in delivering service excellence to all clients and customers across the United States. Our scientific team is recognized industry wide for their expertise in solving complex bioanalytical method development issues quickly and cost effectively, allowing our clients to advance to Phase I studies faster. We look forward to building a collaborative relationship with PRA that not only streamlines project execution but also places a strong emphasis on project management.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters